News
AZ’ COPD therapy wins US approval
AstraZeneca has bagged a green light in the US for Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) as maintenance treatment for patients with chronic obstructive pulmonary disease (COPD), the third leading cause of death globally.